Kangasniemi Marika H, Arffman Riikka K, Haverinen Annina, Luiro Kaisu, Hustad Steinar, Heikinheimo Oskari, Tapanainen Juha S, Piltonen Terhi T
Department of Obstetrics and Gynecology, University of Oulu, Oulu University Hospital and Medical Research Centre PEDEGO Research Unit, Oulu, Finland.
Department of Obstetrics and Gynecology, University of Oulu, Oulu University Hospital and Medical Research Centre PEDEGO Research Unit, Oulu, Finland.
Contraception. 2022 Dec;116:59-65. doi: 10.1016/j.contraception.2022.08.009. Epub 2022 Sep 7.
Ethinylestradiol (EE)-based combined oral contraceptives (COC) affect adrenal function by altering steroid and corticosteroid-binding globulin (CBG) synthesis that may contribute to adverse effects related to these drugs. The effects of COCs containing natural estrogens remain unclear. We compared the effects of COCs containing estradiol valerate (EV) and EE on cortisol and other adrenal steroid hormones.
A spin-off study of a randomized, open-label trial. Fifty-nine healthy women were allocated to groups that engaged in the continuous use of EV+dienogest (DNG), EE+DNG, or DNG only for 9 weeks. We measured changes in adrenal steroids, CBG, and the free cortisol index (FCI).
Treatment with EE+DNG increased total cortisol (mean increment 668 nmol/L, p < 0.001) and cortisone (10 nmol/L, p= 0.001) levels, whereas the change from the baseline was insignificant for the EV+DNG and DNG-only groups. Dehydroepiandrosterone sulfate decreased by 24% in the EE+DNG group but remained unchanged in the EV+DNG and DNG-only groups. Aldosterone and 17-hydroxyprogesterone levels did not differ between the groups. All preparations increased CBG, but the increase in the EE+DNG group (median increment 42 µg/mL, p < 0.001) was 9- and 49-fold higher than that in the EV+DNG and DNG-only groups, respectively. The FCI remained unchanged in all study groups, indicating that cortisol and CBG mainly increased in parallel, although some individuals demonstrated larger alterations in the cortisol-CBG balance.
In COCs, EV had a milder effect on circulating CBG and adrenal steroid levels than EE; however, further research is necessary to determine the long-term effects.
ClinicalTrials.gov NCT02352090 IMPLICATIONS: EV-based COC had reduced effects on circulating CBG and adrenal steroids compared to EE, probably due to a lower hepatic impact. Whether the sensitization of the adrenals to ACTH varies according to COC contents and whether it relates to experienced side effects needs to be investigated. These results encourage further research and development of contraceptives containing natural estrogens.
基于炔雌醇(EE)的复方口服避孕药(COC)通过改变类固醇和皮质类固醇结合球蛋白(CBG)的合成来影响肾上腺功能,这可能导致与这些药物相关的不良反应。含天然雌激素的COC的影响尚不清楚。我们比较了含戊酸雌二醇(EV)和EE的COC对皮质醇和其他肾上腺类固醇激素的影响。
一项随机、开放标签试验的衍生研究。59名健康女性被分配到连续使用EV+地诺孕素(DNG)、EE+DNG或仅使用DNG 9周的组中。我们测量了肾上腺类固醇、CBG和游离皮质醇指数(FCI)的变化。
EE+DNG治疗使总皮质醇(平均增加668 nmol/L,p<0.001)和可的松(10 nmol/L,p=0.001)水平升高,而EV+DNG组和仅使用DNG组与基线相比变化不显著。EE+DNG组硫酸脱氢表雄酮降低了24%,而EV+DNG组和仅使用DNG组保持不变。各组间醛固酮和17-羟孕酮水平无差异。所有制剂均使CBG升高,但EE+DNG组的升高幅度(中位数增加42μg/mL,p<0.001)分别比EV+DNG组和仅使用DNG组高9倍和49倍。所有研究组的FCI均保持不变,表明皮质醇和CBG主要平行升高,尽管一些个体的皮质醇-CBG平衡变化较大。
在COC中,EV对循环CBG和肾上腺类固醇水平的影响比EE更温和;然而,需要进一步研究以确定其长期影响。
ClinicalTrials.gov NCT02352090 意义:与EE相比,基于EV的COC对循环CBG和肾上腺类固醇的影响较小,可能是由于对肝脏的影响较小。肾上腺对促肾上腺皮质激素的敏感性是否因COC成分而异,以及是否与所经历的副作用有关,有待研究。这些结果鼓励对含天然雌激素的避孕药进行进一步研究和开发。